Fennec Pharmaceuticals Inc. · NASDAQ:FENC

Evans Terry L exercised options for 168 Fennec Pharmaceuticals Inc. shares (Form 4)

Traded Apr 30, 2026 · Filed May 1, 2026

On Apr 30, 2026, Evans Terry L (Chief Commercial Officer) exercised options for 168 Fennec Pharmaceuticals Inc. shares, leaving 20,847 shares. Filed May 1, 2026 (Form 4).

Options exercised
168 shares
Holding after
20,847 shares
Trading plan
No
Role
Chief Commercial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 30, 2026Common SharesOption exercise16820,847Direct

Source

View original at SEC

Related